Is CervoMed Stock a Good Investment?
CervoMed Investment Advice | CRVO |
- Examine CervoMed's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research CervoMed's leadership team and their track record. Good management can help CervoMed navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact CervoMed's business and its evolving consumer preferences.
- Compare CervoMed's performance and market position to its competitors. Analyze how CervoMed is positioned in terms of product offerings, innovation, and market share.
- Check if CervoMed pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about CervoMed's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in CervoMed stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if CervoMed is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Good | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine CervoMed Stock
Researching CervoMed's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. CervoMed recorded a loss per share of 2.02. The entity last dividend was issued on the 14th of December 2018. The firm had 2:3 split on the 17th of August 2023.
To determine if CervoMed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CervoMed's research are outlined below:
| CervoMed is way too risky over 90 days horizon | |
| CervoMed appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (16.29 M) with loss before overhead, payroll, taxes, and interest of (9.06 M). | |
| CervoMed generates negative cash flow from operations | |
| About 33.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Is CervoMed Inc. Among the Best Short Squeeze Stocks to Buy According to Analysts |
CervoMed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CervoMed. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CervoMed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact CervoMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises CervoMed's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-09 | 2024-06-30 | -0.31 | -0.27 | 0.04 | 12 | ||
2024-03-29 | 2023-12-31 | -0.29 | -0.38 | -0.09 | 31 | ||
2024-11-11 | 2024-09-30 | -0.41 | -0.5462 | -0.1362 | 33 | ||
2025-03-31 | 2024-12-31 | -0.6343 | -0.8 | -0.1657 | 26 | ||
2023-11-13 | 2023-09-30 | -0.95 | -0.7 | 0.25 | 26 | ||
2018-04-03 | 2018-03-31 | -0.04 | 0.38 | 0.42 | 1050 | ||
2022-08-11 | 2022-06-30 | -2.04 | -3.09 | -1.05 | 51 | ||
2023-08-08 | 2023-06-30 | -2.9 | -1.5537 | 1.3463 | 46 |
CervoMed Target Price Consensus
CervoMed target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. CervoMed's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Buy |
Most CervoMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand CervoMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of CervoMed, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCervoMed Target Price Projection
CervoMed's current and average target prices are 9.37 and 20.00, respectively. The current price of CervoMed is the price at which CervoMed is currently trading. On the other hand, CervoMed's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On CervoMed Target Price
CervoMed Analyst Ratings
CervoMed's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about CervoMed stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of CervoMed's financials, market performance, and future outlook by experienced professionals. CervoMed's historical ratings below, therefore, can serve as a valuable tool for investors.CervoMed's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 77.09 M.Market Cap |
|
CervoMed's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.46) | (0.49) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.42) | (0.44) |
Determining CervoMed's profitability involves analyzing its financial statements and using various financial metrics to determine if CervoMed is a good buy. For example, gross profit margin measures CervoMed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CervoMed's profitability and make more informed investment decisions.
Basic technical analysis of CervoMed Stock
As of the 20th of March, CervoMed shows the Mean Deviation of 6.77, downside deviation of 2.96, and Risk Adjusted Performance of 0.1599. CervoMed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CervoMed's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CervoMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on CervoMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CervoMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand CervoMed's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing CervoMed's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1599 | |||
| Market Risk Adjusted Performance | (1.65) | |||
| Mean Deviation | 6.77 | |||
| Semi Deviation | 1.49 | |||
| Downside Deviation | 2.96 | |||
| Coefficient Of Variation | 585.38 | |||
| Standard Deviation | 20.63 | |||
| Variance | 425.65 | |||
| Information Ratio | 0.175 | |||
| Jensen Alpha | 3.31 | |||
| Total Risk Alpha | 5.79 | |||
| Sortino Ratio | 1.22 | |||
| Treynor Ratio | (1.66) | |||
| Maximum Drawdown | 167.6 | |||
| Value At Risk | (4.46) | |||
| Potential Upside | 11.23 | |||
| Downside Variance | 8.75 | |||
| Semi Variance | 2.23 | |||
| Expected Short fall | (8.76) | |||
| Skewness | 7.19 | |||
| Kurtosis | 54.95 |
| Risk Adjusted Performance | 0.1599 | |||
| Market Risk Adjusted Performance | (1.65) | |||
| Mean Deviation | 6.77 | |||
| Semi Deviation | 1.49 | |||
| Downside Deviation | 2.96 | |||
| Coefficient Of Variation | 585.38 | |||
| Standard Deviation | 20.63 | |||
| Variance | 425.65 | |||
| Information Ratio | 0.175 | |||
| Jensen Alpha | 3.31 | |||
| Total Risk Alpha | 5.79 | |||
| Sortino Ratio | 1.22 | |||
| Treynor Ratio | (1.66) | |||
| Maximum Drawdown | 167.6 | |||
| Value At Risk | (4.46) | |||
| Potential Upside | 11.23 | |||
| Downside Variance | 8.75 | |||
| Semi Variance | 2.23 | |||
| Expected Short fall | (8.76) | |||
| Skewness | 7.19 | |||
| Kurtosis | 54.95 |
Consider CervoMed's intraday indicators
CervoMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CervoMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CervoMed Corporate Filings
8K | 18th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 17th of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 14th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of January 2025 Other Reports | ViewVerify |
CervoMed Stock media impact
Far too much social signal, news, headlines, and media speculation about CervoMed that are available to investors today. That information is available publicly through CervoMed media outlets and privately through word of mouth or via CervoMed internal channels. However, regardless of the origin, that massive amount of CervoMed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CervoMed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CervoMed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CervoMed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CervoMed alpha.
CervoMed Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards CervoMed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CervoMed Corporate Management
| Mark Rosch | SVP Management | Profile | |
| Claudia MD | Senior Science | Profile | |
| John Tanner | Chief Officer | Profile | |
| William JD | General Secretary | Profile | |
| Kelly MHA | Senior Development | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.02) | Revenue Per Share | Quarterly Revenue Growth (0.13) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between CervoMed's value and its price, as these two are different measures arrived at by various means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.